Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

China · Delayed Price · Currency is CNY

9.24

-0.21 (-2.22%)

Sep 10, 2026, 3:04 PM CST

Market Cap	4.83B +7.4%
Revenue (ttm)	826.71M -4.4%
Net Income	74.77M +34.0%
EPS	0.14 +21.1%
Shares Out	510.74M
PE Ratio	67.25
Forward PE	n/a
Dividend	0.15 (1.67%)
Ex-Dividend Date	Jun 18, 2026

Volume	12,205,216
Open	9.45
Previous Close	9.45
Day's Range	9.22 - 9.50
52-Week Range	7.66 - 15.21
Beta	1.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:002728

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company’s products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 an... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 1,434

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002728

Full Company Profile

Financial Performance

In 2025, SHE:002728's revenue was 924.53 million, an increase of 34.42% compared to the previous year's 687.79 million. Earnings were 81.67 million, an increase of 298.50%.

Financial Statements